FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
ETFMG Treatments, Testing and Advancements ETF Stock AnalysisComprehensive stock analysis for ETFMG Treatments, Testing and Advancements ETF (GERM) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisGERM
GERM
ETFMG Treatments, Testing and Advancements ETF
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GERM
Home🔹Stocks🔹ETFMG Treatments, Testing and Advancements ETF

ETFMG Treatments, Testing and Advancements ETF

GERM•AMEX

ETFMG Treatments, Testing and Advancements ETF

GERM•AMEX
Market cap
$9.59M
Sentiment

Your view on GERM

Mkt Cap
$9.59M
Sentiment
Your view
GERM
ETFMG Treatments, Testing and Advancements ETF
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
GERM
Company Overview

Overview

What the company does, where it operates, and who runs it.

About ETFMG Treatments, Testing and Advancements ETF

Industry
Asset Management
Sector
Financial Services
CEO
Not available
Headquarters
3333 Warrenville Road, Lisle, IL, US
Industry
Asset Management
Sector
Financial Services
CEO
Not available
Headquarters
3333 Warrenville Road, Lisle, IL, US
Description

This fund aims to replicate the investment performance of U.S.-listed companies, including equity shares and depositary receipts, that are primarily engaged in two sectors: either researching, developing, and bringing to market treatments or vaccines for infectious diseases, or producing, researching, and supplying biological diagnostic tests for patients. At least 80% of the fund's total assets will be invested in the specific securities that constitute its underlying index. It is important to note that this fund is structured as non-diversified.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

FRC's fair value estimate for ETFMG Treatments, Testing and Advancements ETF, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for ETFMG Treatments, Testing and Advancements ETF. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for ETFMG Treatments, Testing and Advancements ETF. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for ETFMG Treatments, Testing and Advancements ETF. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for ETFMG Treatments, Testing and Advancements ETF. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

ETFMG Treatments, Testing and Advancements ETF valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold ETFMG Treatments, Testing and Advancements ETF, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by ETFMG Treatments, Testing and Advancements ETF executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming ETFMG Treatments, Testing and Advancements ETF. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming ETFMG Treatments, Testing and Advancements ETF. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for ETFMG Treatments, Testing and Advancements ETF. Press releases and market coverage, newest first.

News

Latest Market News